| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Ticagrelor | FAERS: 183 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 2 | bivalirudin | FAERS: 19 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 3 | Prasugrel Hydrochloride | FAERS: 18 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 4 | Clopidogrel | FAERS: 12 | US FAERS | |
| 5 | Prasugrel Hydrochloride | FAERS: 10 | US FAERS | |
| 6 | Clopidogrel | FAERS: 8 | US FAERS | |
| 7 | Rivaroxaban | FAERS: 7 | US FAERS | |
| 8 | Dabigatran | FAERS: 6 | US FAERS | |
| 9 | cangrelor | FAERS: 5 | US FAERS | |
| 10 | Fluorouracil | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 11 | Warfarin | FAERS: 3 | US FAERS | |
| 12 | Argatroban monohydrate | FAERS: 2 | US FAERS | |
| 13 | Eptifibatide | FAERS: 2 | US FAERS | |
| 14 | apixaban | FAERS: 2 | US FAERS | |
| 15 | 4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide | FAERS: 1 | US FAERS | |
| 16 | Aspirin | FAERS: 1 | US FAERS | |
| 17 | Lenalidomide | FAERS: 1 | US FAERS | |
| 18 | Mesalamine | FAERS: 1 | US FAERS | |
| 19 | Paclitaxel | FAERS: 1 | US FAERS | |
| 20 | Ranolazine | FAERS: 1 | US FAERS | |
| 21 | Tadalafil | FAERS: 1 | US FAERS | |
| 22 | Testosterone | FAERS: 1 | US FAERS | |
| 23 | Tranexamic Acid | FAERS: 1 | US FAERS | |
| 24 | Vitamin K 1 | FAERS: 1 | US FAERS | |
| 25 | Warfarin | FAERS: 1 | US FAERS | |
| 26 | edoxaban | FAERS: 1 | US FAERS | |
| 27 | reviparin | FAERS: 1 | US FAERS |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.